Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC

The Genotype to Phenotype Japan (G2P-Japan) Consortium

doi:10.1016/S1473-3099(24)00810-7

Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC

The Genotype to Phenotype Japan (G2P-Japan) Consortium

Department of Laboratory Medicine

Research output: Contribution to journal › Letter › peer-review

21 Citations (Scopus)

Original language	English
Pages (from-to)	e61
Journal	The Lancet Infectious Diseases
Volume	25
Issue number	2
DOIs	https://doi.org/10.1016/S1473-3099(24)00810-7
Publication status	Published - 2025 Feb

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1016/S1473-3099(24)00810-7

Cite this

@article{12500643e22945a1b7f785715f6975bc,

title = "Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC",

author = "\{The Genotype to Phenotype Japan (G2P-Japan) Consortium\} and Keiya Uriu and Yu Kaku and Yoshifumi Uwamino and Hiroshi Fujiwara and Fumitake Saito and Kei Sato",

year = "2025",

month = feb,

doi = "10.1016/S1473-3099(24)00810-7",

language = "English",

volume = "25",

pages = "e61",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd",

number = "2",

}

TY - JOUR

T1 - Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC

AU - The Genotype to Phenotype Japan (G2P-Japan) Consortium

AU - Uriu, Keiya

AU - Kaku, Yu

AU - Uwamino, Yoshifumi

AU - Fujiwara, Hiroshi

AU - Saito, Fumitake

AU - Sato, Kei

PY - 2025/2

Y1 - 2025/2

UR - https://www.scopus.com/pages/publications/85215212830

UR - https://www.scopus.com/pages/publications/85215212830#tab=citedBy

U2 - 10.1016/S1473-3099(24)00810-7

DO - 10.1016/S1473-3099(24)00810-7

M3 - Letter

C2 - 39672184

AN - SCOPUS:85215212830

SN - 1473-3099

VL - 25

SP - e61

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 2

ER -

Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this